KALV Operating Expenses

Kalvista Pharmaceuticals Inc · Operating Expenses

KALV logo

KALV Operating Expenses

Latest reported$246.68M
KALV TTM Operating Expenses ($11.71M → $246.68M)
High-resolution chart · PNG

KALV operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Kalvista Pharmaceuticals Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
246,675,500
218,354,000
200,434,000
187,735,000
172,105,000
156,173,000
146,177,000
111,023,000
76,594,000
61,164,000
35,102,000
32,251,000
30,595,000
30,416,000
50,217,000
66,014,000
77,400,000
75,967,000
61,941,000
51,119,000
46,046,000
43,177,000
44,821,000
45,249,000
43,739,000
54,629,000
50,878,000
48,154,000
45,948,000
39,571,000
35,698,000
32,277,000
27,099,000
24,490,000
26,178,000
21,526,000
18,389,000
18,264,000
15,476,000
17,970,000
21,232,000
21,065,000
19,313,000
17,985,000
14,752,000
11,706,000
9,365,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.